Picture of Terns Pharmaceuticals logo

TERN — Terns Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapNeutral

Brief: Terns Pharmaceuticals Q3 Net Income USD -24.635 Million Vs. IBES Estimate USD -27.2 Million

Nov 10 (Reuters) - Terns Pharmaceuticals Q3 pretax profit USD -24.589 million vs. IBES estimate USD -27.2 million.

Q3 operating expenses USD 27.716 million

Q3 income from operations USD -27.716 million vs. IBES estimate USD -29.5 million

Q3 basic EPS USD -0.27

Recent news on Terns Pharmaceuticals

See all news